Prof. Janet Mary Daly

Janet M. Daly is a Professor of Viral Zoonoses at the Faculty of Medicine & Health Sciences, University of Nottingham, UK, and a Fellow of the Royal College of Pathologists. She gained her PhD on antigenic and genetic variation in equine influenza viruses and its impact on vaccine efficacy from the Open University on a part-time basis while working at a veterinary institute (the Animal Health Trust). In 1995, she moved into the human influenza field, first at the National Institute of Biological Standards and Control studying the safety and immunogenicity of DNA vaccines, then at Glaxo Wellcome (now Glaxo Smithkline) where she was involved in studies of the influenza antiviral zanamivir. She returned to the Animal Health Trust in 2001 where she worked closely with veterinary vaccine manufacturers in the conduct of vaccine efficacy studies. She moved to the University of Liverpool to study the immunopathology of the Japanese encephalitis virus, and finally joined the School of Veterinary Medicine and Science at the University of Nottingham in 2009. She is currently involved in studying various aspects of emerging and re-emerging RNA viruses including the development of antivirals and vaccines.